Signaling path of the action of AVP on distal K + secretion. Background. Previous studies from our laboratory have shown that luminal perfusion with arginine vasopressin (AVP) stimulates distal tubule secretory potassium flux (J K ) via V1 receptors (Am J Physiol 278: F809-F816, 2000). In the present work, we investigate the cell signaling mechanism of this process.
ber of factors, including potassium metabolism, sodium balance, acid-base balance, and hormones such as aldosterone and vasopressin, among others.
In a previous work we have observed a luminal effect of arginine vasopressin (AVP) when cortical distal tubules were perfused with this hormone at concentrations between 10 −11 and 10 −9 mol/L. This effect was mediated by V1 receptors, since it was abolished by the V1 receptor antagonist (b-mercapto-b-cyclopentamethylenepropionyl-o-me-tyr 2 -arg 8 vasopressin), and not by the V2 receptor antagonist (adamantaneacetylo-et-d-tyr 2 , val 4 aminobutyryl 6 , arg 8, 9 vasopressin) [2] . It is known that vasopressin acts on V1 receptors in vascular smooth muscle cells via phospholipase C (PLC)/inositol 3,4,5-triphosphate (IP 3 )/calcium signaling [3] [4] [5] . On the other hand, it was shown that when microdissected cortical collecting tubules are incubated with vasopressin, potassium secretion is stimulated by increasing the density of apically active renal outer medullary K + channel (ROMK) channels via a cyclic adenosine monophosphate-protein kinase A (cAMP-PKA) pathway [6] . This finding is supported by studies on the thick ascending limb, where treatment with 1-desamino D-Arg 8 -vasopressin (dDAVP), a specific V2 agonist, also increased the density of apical ROMK channels [7] . These observations suggested that stimulation of potassium secretion by vasopressin might be due to V2 receptor and cAMP-PKA activation. On the other hand, our data showing luminal action of vasopressin via V1 receptors on distal potassium secretion suggest two possibilities. Either vasopressin is able to stimulate potassium secretion by way of two signaling pathways, starting with V1 and V2 receptors, or V1 activation at the apical cell membrane may stimulate K secretion via the same path of basolateral V2 receptor activation [i.e., the G s protein (adenylate cyclase-cAMP-PKA pathway)].
The present study investigates the mechanism of cell signaling of the effect of luminal action of 10 −11 mol/L vasopressin via V1 receptors. As will be evidenced below, the alternative of activation of potassium secretion by the protein kinase C (PKC) path is the preferred mechanism, but our present evidence together with previous data from the literature [6, 8] , suggests that initial collecting duct cells have both V1 and V2 receptors and respond to both cAMP (V2) and PKC (V1) mechanisms, possibly acting on different K + channels.
METHODS
Male Wistar rats weighing 210 to 300 g were anesthetized with inactin, 100 mg/kg, and prepared for in vivo micropuncture as described previously [2] . Stationary microperfusion experiments were performed as shown schematically in Figure 1 . A proximal tubule was punctured by a double-barreled micropipette, one barrel being used to inject FDC-green-colored perfusion solution, and the other to inject Sudan-black-colored castor oil used to block the injected fluid columns in the lumen. The control solution contained 100 mmol/L NaCl, 20 mmol/L Na Hepes, 0.5 mmol/L KCl, 1 mmol/L CaCl 2 , and raffinose (added to minimize fluid reabsorption) to reach an osmolality of 300 mOsm. pH was adjusted to 6.5. This solution contained AVP in the concentrations given in the Results section, depending on the specific experiment. A single micropipette containing the same Ringer solution plus the signaling agent or channel inhibitor was impaled in a neighboring loop. A late distal segment of the same nephron, recognized by the colored perfusion and by having a transepithelial potential difference (PD) of more than 20 mV, lumen negative, was impaled by a double-barreled asymmetric microelectrode (WPI, Sarasota, FL, USA), the larger barrel containing at its tip, after silanization with hexamethyldisilazane, the potassium-ion sensitive ion-exchange resin (both from Fluka, Buchs, Switzerland) and the smaller, 0.24 mol/L NaCl and 0.76 mol/L Na acetate, colored by FDC-green. This potassium-free solution was calculated to have mean similar cation and anion mobilities. The microelectrode had a tip diameter of approximately 1 lm, and the reference barrel a resistance of less than 10 MOhm. Additional properties of the microelectrode were described previously [9] . Standards had a composition of 3, 10, or 30 mmol/L KCl and 100 mmol/L NaCl were added to each of these solutions. Decade voltage difference for K + ranged from 40 to 45 mV. The electrodes were calibrated before and after every impalement by superfusion of the kidney surface with standards at 37
• C. Perfusions were performed by air-filled syringes connected to the micropipette holders by polyethylene tubing, at a rate sufficient to lower luminal potassium concentrations to values near those of the perfusion fluid (i.e., 0.5 mmol/L).
Every tubule was perfused first with control solutions (AVP-free), then with solutions containing AVP or solutions with AVP and experimental modifiers of transport, allowing for paired measurement of K + secretion. By this technique a mean of several (about two to four) control and experimental curves were obtained, constituting the pair of values for this tubule. The value of n given for an experimental condition corresponds to the number of perfused tubules, approximately one to three being perfused in one rat. Statistical evaluation was performed by the paired t test, comparing the means of control and experimental values of every tubule. Details of the experimental procedure have been given before [2, 10] . The voltage between the microelectrode barrels was sampled every second by an AD converter (Lynx, São Paulo, Brazil) in a microcomputer (Dell model 333D). At the same time, the difference between the reference barrel PD and ground (the rat tail) was recorded, giving the evolution of transepithelial PD with time during the perfusion. The data were analyzed by a Visual Basic program using the Excel (Microsoft) software. The half-time (t1 / 2 ) of the approach of K + activities to their stationary level was obtained, as well as the stationary K + activity and PD. Secretory K + fluxes (J K ) were obtained by the following relationship:
where t1 / 2 is the half-time of K + activity increase toward the stationary level, K s is the stationary K + activity, K o is the initial K + activity (taken as 0.5 mmol/L), and r is the tubule radius [9, 11] .
Vasopressin (9) 27.7 ± 2.91 12.9 ± 1.07 (9) 23.5 ± 4.09 a AVP + tetraethylammonium 27.9 ± 2.72 (8) 27.4 ± 2.41 9.2 ± 1.00 (8)
19.3 ± 1.88 (7) 17.5 ± 1.70 8.14 ± 1.08 (7) 11.8 ± 1.59 a
Luminal perfusion (14) 21.9 ± 2.34 9.3 ± 0.95 (14) 13.5 ± 1.39 a BAPTA, bis aminophenoxy ethane-tetraacetic acid. a P < 0.05 vs. AVP 10
Statistical comparisons were made by the paired t test, taking the probability of 0.05 (5%) as the limit of significance. Tables 1 and 2 give the basic data from which rates of potassium secretion were calculated according to equation 1 [i.e., stationary potassium concentrations (K s ) and half-times of the approach of luminal K + levels to the stationary concentrations (t1 / 2 )]. It is noted that the differences between experimental groups are mostly due to modifications in t1 / 2 rather than in K s , that is, the critical value is the rate at which the luminal K + level approaches its steady-state. Table 3 gives the transepithelial PD for the experiments performed in this series. Most of mean PD values show no significant differences between groups.
RESULTS
In the following, we will present mean potassium secretion rates for the different experimental conditions studied in this work. Mean values for the different groups are given in Table 4 . In Figure 2 and Table 4 , it is noted that luminal perfusion with 10 −5 mol/L 8-bromo-cAMP reduces K + secretion significantly, by 14%, indicating that cAMP at the applied level does not increase but reduces potassium transport by this tubule segment. During luminal perfusion with 10 −8 mol/L PMA, an activator of PKC, K + secretion is increased markedly, by 35%, with PMA (see Fig. 2B ). When 10 −4 mol/L H89, an inhibitor of the action of PKA, is added to luminal AVP (see Fig. 3A ), no change in K + secretion is observed, supporting the view that AVP action is not dependent on the activity of the cAMP/PKA pathway. Figure 3B shows that 10 −5 mol/L staurosporine, an inhibitor of PKC, abolishes the stimulatory effect of AVP on K + secretion, reducing J K by 41% when staurosporine was perfused. Taken together, these experiments indicate that the PLC/IP 3 /PKC signaling path probably mediates the action of luminal AVP on potassium transport. Figure 4 and Table 4 show that luminal perfusion with AVP plus 10 −5 mol/L BAPTA-am, an intracellular calcium chelator known to reduce cell Ca 2+ levels [12, 13] , blocked the luminal action of AVP, reducing J K by 40.2%, indicating that cell calcium plays an important role in the action of the hormone. It is interesting to observe that the value of J K after staurosporin and after BAPTA are very similar, showing that in both situations the stimulating effect of AVP was blocked to the same extent, which is suggestive of action of these agents on the same signaling path.
It has been shown that the most important channels for distal K + secretion are the small conductance channels, the ROMK channels [14, 15] . These channels are not directly Ca 2+ -dependent, as opposed to our findings for the luminal AVP effect (see above); on the other hand, the voltage-dependent maxi-potassium channels, of large conductance (70 to 120 pS), which have been found in a large number of cells, including renal epithelial cells [16] [17] [18] , are Ca 2+ -dependent. These channels are blocked by TEA. Figure 5 shows that 5 mmol/L TEA significantly inhibits K + secretion in the presence of luminal AVP, reducing J K measured in the presence of AVP, by 31%. This suggests that Ca 2+ -dependent K + channels might participate in distal potassium secretion, being responsible for the action of the hormone on this transport mechanism. This hypothesis was strengthened by the use of a more specific inhibitor of Ca 2+ -dependent K + channels, iberiotoxin, which reduced the effect of luminal AVP by 36.6% (see Fig. 6A ) ( Table 4 ). This toxin, in the same way as charybdotoxin, both derived from scorpion venom, has been shown to block these channels with great specificity [19] . Figure 6B shows studies investigating the effect of iberiotoxin on AVP-independent potassium secretion. For this purpose, tubules were perfused with a blocker of V1 receptors for AVP (b-mercapto-bb-cyclopenta-methylenepropionyl 1 ,O-Me-Tyr 2 -Arg 8 vasopressin) (AV1), which was used since endogenous AVP may affect basal K + secretion [2] . It is noted that the effect of iberiotoxin observed during these perfusions is much smaller (J K (AV1) − J K (AV1 + IBX) = 0.13 ± 0.063 nmol.cm −2 .seconds −1 ) than that found in the experiments with luminal perfusion with AVP 10 −11 mol/L ( J K = 0.34 ± 0.074). These findings indicate that Ca 2+ -dependent potassium channels very probably are the site at which AVP stimulates K + secretion by initial collecting duct.
DISCUSSION
A number of experimental reports have shown that potassium secretion by distal nephron segments is stimulated by AVP [20] [21] [22] . In spite of marked reduction in urine flow during venous infusion of AVP in Brattleboro rats, fractional K + excretion increased by 77%; in free-flow micropuncture performed in these rats it was shown that this increase occurred beyond the late distal tubule, but it was significant in microperfused cortical distal tubules (initial collecting duct) [20] . Pretreatment with deoxicorticosterone has been shown to enhance the AVP effect in the rat cortical collecting duct perfused in vitro. Under these conditions, AVP caused a fourfold increase in net sodium reabsorption and a threefold increase in net potassium secretion [21] . An effect of AVP on potassium transport, however, was not found in isolated perfused collecting duct of the rabbit [22] . In addition, bath to lumen unidirectional fluxes of 86 Rb + in isolated perfused rat cortical collecting duct increased by approximately 180% when 100 lU/mL of AVP were added to the bathing solution [23] . These findings indicated that AVP was able to exert a significant stimulating effect on potassium transport in rat cortical collecting duct.
The mechanism by which this effect of AVP occurs has been investigated. It has been proposed that AVP acted by increasing the electrochemical driving force for K + across the apical cell membrane [24] . However, our observations that in most situations no significant changes in the stationary potassium concentration in the lumen and of transepithelial PD were observed argue in favor that the electrochemical potential difference for K + across the apical membrane (assuming constant cell K + during the short experimental period) is probably not the determining factor for the differences in K + secretion found in these experiments. This finding is compatible with data showing that the density of low-conductance (ROMK) potassium channels at the apical membrane of principal cells of rat cortical collecting duct measured by the patchclamp technique increased when 10 −10 mol/L AVP was added to the solution bathing split-open tubules [6] . An increase of the density of apical channels would be equivalent to a higher apical potassium conductance and to a reduction of the half-time of potassium equilibration in the tubule lumen as shown in our experiments.
The patch-clamp study on ROMK channels cited above indicated that dibutiryl cAMP and forskolin also increased channel density, suggesting that the effect of AVP on these channels was mediated by adenylate cyclase/cAMP/PKA, a signaling path that has been shown to mediate the increase in water permeability induced by this hormone [25] . This path is dependent on V2 receptors of AVP, present on the basolateral cell membrane, which is apparently incompatible with our finding of V1 receptor dependence of the apical membrane effect of AVP [2, 26] . The latter effect is more compatible with V1 mediated action of AVP, which has been shown in vascular smooth muscle cells and which is mediated by cell Ca 2+ and PKC [3] . This V1-mediated effect has been found, in vascular smooth muscle, at AVP concentrations down to 10 −11 mol/L, and has been blocked by PKC inhibitors such as staurosporine, which abolished the Ca 2+ spiking seen in these cells caused by AVP [3] . Actually, about 20% of total AVP receptors in cortical collecting duct are of the V1 type, which should then constitute an important mechanism of AVP action in this structure [27] . Our data show that the luminal action of AVP is mediated by V1 receptors, and is signaled by the PLC-IP 3 [28, 29] . In addition, the PKA inhibitor H89 (10 −4 mol/L), in the presence of 10 −11 mol/L AVP, did not affect K + secretion, indicating that PKA was no part of the stimulatory mechanism of AVP on this process.
Another signaling cascade that may be active in the V1 effect of AVP is the PLC/PKC cascade. As mentioned above, this is the cascade involved in the action of AVP via V1 receptors in vascular smooth muscle [3] . PMA, 10 −8 mol/L, which is a PLC stimulating agent, had a significant stimulating effect on distal K + secretion. On the other hand, the PKC inhibitor staurosporine 10 −5 mol/L caused a marked reduction of K + secretion in the presence of 10 −11 mol/L AVP, suggesting a role for PKC in AVP action. The PLC/IP 3 /PKC path is also known to involve an increase in cell Ca 2+ , which acts as a second messenger and activates PKC by transferring cytosolic PKC to the cell membrane [4, 30, 31] . In order to investigate if this messenger might be also active in luminal AVP function, tubules were perfused with AVP plus 10 −5 mol/L BAPTA-am, an intracellular calcium chelator known to reduce cell Ca 2+ levels [13] . A significant reduction of K + secretion was observed, indicating a dependence of this transport on the cellular calcium level. Taking these observations together, they suggest that the most important signaling path for the luminal effect of AVP on potassium secretion is the PLC/PKC/Ca 2+ system, which is compatible with the known path related to the V1 receptors of AVP in other tissues such as vascular smooth muscle cells.
Our findings of potassium secretion signaling via the PKC path are apparently at variance with a number of studies on K + channels. We have shown before that the action of AVP on potassium secretion is due to an effect of this hormone on K + channels, and not on the KCl-cotransport mechanism, which has been localized to the apical cell membrane of the late distal tubule [2, 10] . We have mentioned above that there is evidence for cAMP/PKA-mediated regulation of the apical density of low conductance (ROMK) channels [6] . It was referred, also, that PKC or phorbol ester inhibit these channels, and that an increase in cell calcium decreases their activity [8, 32] . These findings are compatible with the presence of phosphorylation sites for PKA and PKC on the cytoplasmic COOH-terminus of the ROMK molecule [33] . However, it must be taken into consideration that the described studies were performed with the patch-clamp technique, and are specific for the lowconductance potassium channel. It has been considered that these are the channels responsible for most of the apical potassium secretory mechanism [14] . However, other potassium channels have been found at this site, and particularly the calcium and voltage dependent large (or medium) conductance channel has been described + and might have an important role in potassium secretion. Early investigations detected the presence of these channels in cultured chicken kidney cells [34] and in rabbit cortical collecting duct [35] . In the cultured cells, it was found that AVP stimulated the activity of these channels [34] . Madin-Darby canine kidney (MDCK) cells (cultured distal renal cells) have also been shown to have maxi-potassium channels at their apical surface by the patch-clamp technique. These channels depended on Ca + and were regulated by PKC, since they were markedly stimulated by phorbol ester [36] . These channels have a low open probablity at normal calcium and cell potential; however, agents such as angiotensin and AVP increase cell calcium [37, 38] . In addition, late distal tubule and cortical collecting duct have partly depolarized apical cell membranes, mostly due to the presence of EnaC sodium channels. More recently, it was shown that these K + channels were in large part responsible for the flowdependent increase in potassium secretion, both in adult and in developing rats [39] .
A number of inhibitors for the maxi-potassium channels have been described. TEA has been shown repeatedly to reduce the open probability of these channels [33] , but the specificity of TEA toward maxi-potassium channels is limited. More recently, toxins derived from scorpion venom such as charybdotoxin and iberiotoxin have been used [40] . Charybdotoxin was used to isolate and purify the high-conductance, Ca ++ dependent (maxipotassium) potassium channel [41] . Iberiotoxin has been shown to be even more specific for Ca 2+ dependent K + channels, since charybdotoxin has also an effect on ROMK potassium channels [42] . Iberiotoxin is referred to be more potent than charybdotoxin in oocytes transfected with maxi-potassium channels [43] ; it is also referred to block maxi-potassium channels at their extracellular mouth, in the same way as TEA [44] . The observations discussed above and our data with TEA and iberiotoxin suggest that the channels stimulated by AVP in our experiments are probably the high-conductance, Ca 2+ and voltage-dependent potassium channels, in general called maxi-(or midi-) potassium channels, with a conductance of 70 to 100 pS. They are sensitive to vasoconstrictor concentrations of AVP interacting with the V1 receptor in smooth muscle cells (10 −11 to 10 −10 mol/L), via the PKC system. PKC involves a number of isoforms; it was shown that PKC a and d are those most involved in the epithelial action of AVP [3] . Of course, our present data do not permit to distinguish between these isoforms. Our results have also confirmed (see Fig. 6 ) that in the absence of stimulation by AVP, that is, in the presence of a V1 receptor antagonist, the participation of these maxi-potassium channels in K + secretion is minor, while most of the AVP dependent increase in K + secretion is mediated by Ca 2+ -dependent maxi-K On the basis of our experimental results and data from the literature, Figure 7 shows in a schematic way the main signaling paths for the action of AVP on potassium transport in initial collecting duct cells of the kidney. The first mechanism described for AVP action on J K involves basolateral V2 receptors, in a way similar to the effect on water permeability [6] . AVP stimulates V2 receptors, which activate G s protein, which in turn activates adenylyl cyclase to liberate cAMP, leading to activation of PKA and of the low conductance potassium channel (ROMK). On the other hand, according to our own data, AVP may also stimulate luminal V1 receptors, which activate protein G q , then PLC and the path phosphoinositol diphosphate (PIP 2 ), IP 3 , liberation of Ca 2+ , or PLC-PIP 2 -DAG-PKC, both ways leading to activation of the apical maxi-potassium channels [2, 3] . This alternative explains why potassium channels may be activated both by PKA and PKC pathways, and how different effects may be observed with basolateral and apical stimulation. This description is compatible with the action of AVP on both low and high conductance potassium channels, and with involvement of V1 (apical membrane) and V2 (basolateral membrane) receptors in distal nephron potassium secretion [45] [46] [47] [48] [49] .
What could be the physiologic role of the observed stimulation of K + secretion by AVP? It is well known that K + transport across the distal tubule epithelium depends markedly on the rate of fluid flow along the tubule, increasing at high flow and decreasing at reduced flow [39, 50] . When animals are dehydrated or their extracellular volume is depleted, urine flow is markedly reduced and plasma and urine AVP levels are increased [51] . Under these conditions, the reduction of K + secretion caused by the diminished urine flow would be compensated by the stimulating action of AVP, contributing to maintain the potassium balance of the body. 
